Virtual screening to identify potent sepiapterin reductase inhibitors.
Gao, H., Schneider, S., Andrews, P., Wang, K., Huang, X., Sparling, B.A.(2020) Bioorg Med Chem Lett 30: 126793-126793
- PubMed: 31740247 
- DOI: https://doi.org/10.1016/j.bmcl.2019.126793
- Primary Citation of Related Structures:  
6USN - PubMed Abstract: 
Sepiapterin reductase has been identified as a potential drug target for neuropathic and inflammatory pain. Virtual screening was executed against a publicly available x-ray crystal structure of sepiapterin reductase. A set of structurally diverse and potent sepiapterin reductase inhibitors was identified. This set of compounds with favorable ligand efficiency and lipophilic efficiency are tractable for further optimization. An SAR follow-up library was synthesized based on one of the virtual screening hits exploring SAR.
Organizational Affiliation: 
Therapeutic Discovery, Amgen Inc., 360 Binney Street, Cambridge 02142, United States. Electronic address: hgao@amgen.com.